Results 181 to 190 of about 14,935 (222)
Some of the next articles are maybe not open access.

Erythrocyte exchange and leukapheresis in pregnancy

Transfusion and Apheresis Science, 2015
Hematological diseases in pregnancy should be carefully managed with a multidisciplinary approach, which should include obstetrics, hematology and, in selected patients, apheresis professionals. Hematological malignancies in pregnant women are rare, but the attending physicians should be aware that the use of cytotoxic drugs, tyrosine-kinase inhibitors
openaire   +2 more sources

Leukapheresis in the treatment of Sézary syndrome

Journal of the American Academy of Dermatology, 1981
Five patients received leukapheresis therapy for Sézary syndrome. All patients had erythroderma, lymphocytic band infiltration of the skin, and a normal white blood cell count with an absolute Sézary cell count of more than 1,000/mm3. Improvement in 3 to 6 months occurred, usually with the addition of a combined regimen of prednisone and low-dose ...
A A, Pineda, R K, Winkelmann
openaire   +2 more sources

Viability of Granulocytes Obtained by Filtration Leukapheresis

Transfusion, 1975
Nylon filtration alters the morphology of human granulocytes and slightly reduces their phagocytic ability as measured by activation of the hexose monophosphate shunt (HMS) pathway of glucose metabolism. In addition, the ability of rat granulocytes to circulate in granulocytopenic rats is reduced, and this is not attributed to HMS activation during ...
A J, Roy   +3 more
openaire   +2 more sources

Pulmonary and systemic effects of mononuclear leukapheresis

Vox Sanguinis, 2012
Background and Objectives  There is increasing evidence that monocytes play a key role in the pathogenesis of acute lung inflammation. Mononuclear cell (MNC) leukapheresis can be used to remove large numbers of monocytes from circulating blood; however, the detailed characteristics of monocyte subpopulations removed by MNC leukapheresis, and the ...
Barr L   +8 more
openaire   +3 more sources

Abdominal pain in donors during filtration leukapheresis

Transfusion, 1977
An unusual donor reaction characterized primarily by lower abdominal and/or perineal pain occurs in 1.2 per cent of donors during filtration leukapheresis (FL). The reaction occurs almost exclusively in female donors. Corticosteroid pretreatment appears to be highly effective in preventing the reaction.
T B, Wiltbank   +3 more
openaire   +2 more sources

Leukapheresis in leukemia.

Progress in clinical and biological research, 1982
Leukapheresis by continuous flow centrifugation was employed in the management of both acute and chronic leukemia. Cytareduction is an effective method of preventing leukostasis in acute leukemia and reducing leukocytosis in chronic leukemia. A report of 55 leukapheresis experiences with 32 patients is described.
openaire   +1 more source

[Therapeutic leukapheresis in tricholeukocytic leukemia].

Annales de medecine interne, 1984
Therapeutic leukapheresis was performed in a patient with hairy cell leukaemia (100,000 WBC/mm3; 98 p. 100 hairy cells) without signs of hypersplenism. Twenty-five sessions were carried out in 12 weeks. A rapid and significant improvement was observed with the WBC falling to 25,000 WBC/mm3 with 70 p. 100 of hairy cells and the normalisation of the bone
G, Karsenty   +4 more
openaire   +1 more source

Leukapheresis in the Sézary Syndrome

1982
Leukapheresis therapy for the Sezary syndrome has been shown to be practical, safe, and effective. It has been performed in patients with elevated and normal white blood cell counts whose Sezary cell index was greater than 1000/mm3 and in pre-Sezary patients whose count was less than 1000/mm3. It was found in our series that improvement can occur for a
R. K. Winkelmann   +3 more
openaire   +1 more source

Leukapheresis and granulocyte transfusion.

Haematologia, 1982
Newer cell separators can collect more PMN, especially using macromolecular agents and steroid stimulation of donors. Proper indications for PMN transfusion are severe neutropenia and sepsis, or certain localized infections, when prolonged marrow aplasia is expected. Optimal dosage is at least 2 x 10(10) PMN per day, probably more.
openaire   +1 more source

Leukapheresis for Hyperviscosity

Transfusion, 1979
S K, Ballas, J K, Kiesel
openaire   +2 more sources

Home - About - Disclaimer - Privacy